MapLight Therapeutics, Inc. SEC filings MPLT

MapLight Therapeutics, Inc. has 209 filings in SEC EDGAR's recent list, going back to Mar 8, 2019. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026 (material agreement, results of operations, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
424B3 Prospectus Sep 23, 2026 —
S-1/A Amended registration statement Sep 18, 2026 —
S-1 Registration statement Sep 9, 2026 —
S-8 Employee stock plan registration Mar 26, 2026 —
424B3 Prospectus Oct 27, 2025 —
S-8 Employee stock plan registration Oct 27, 2025 —
FWP Free writing prospectus Oct 27, 2025 —
FWP Free writing prospectus Oct 6, 2025 —
S-1/A Amended registration statement Oct 6, 2025 —
S-1 Registration statement Sep 19, 2025 —

Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
MPLT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Redwood City, CA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1770069
Former names
Alvarado Therapeutics, Inc. (until Mar 22, 2019)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.